Parenting Boss

Reviewed by Emily Henderson, B.Sc.Aug 10 2020 Only half of pregnant women worldwide who need a treatment developed over 50 years ago to prevent Rh disease–an often-fatal condition in fetuses and newborns that is now exceedingly rare in the United States and Western Europe–actually receive it, finds a study led by researchers at Vagelos College

Reviewed by Emily Henderson, B.Sc.Aug 12 2020 The study of children’s interactions with robots was carried out at the Norwegian research fair held in every major city. It is an annual national event where children gain insight into science and what researchers do. Roger A. Søraa and his research team at the Norwegian University of

Reviewed by Emily Henderson, B.Sc.Aug 10 2020 Young adults and adolescents who are prescribed opioids for the first time may be at a slightly greater risk of developing a substance-related problem later in life, according to a new study co-authored by Indiana University researchers. However, the risk may not be as high as previously thought.

A single intravenous dose of MRG-110, an anti-microRNA drug, significantly reduced miR-92a levels in the blood of healthy humans. Inhibition of miR-92a has shown beneficial effects in animal models, including improved vascularization after myocardial infarction, and accelerated wound healing, according to the peer-reviewed journal Nucleic Acid Therapeutics. “Based on documented, promising therapeutic potential, locked nucleic

A team of researchers at Children’s Hospital of Philadelphia (CHOP) affiliated with the CHOP Epilepsy Neurogenetics Initiative (ENGIN) further bridged the gap between genomic information and clinical outcome data by systematically linking genetic information with electronic medical records, focusing on how genetic neurological disorders in children develop over time. The findings were published today in

As the coronavirus pandemic actively spreads around the world, previous data have shown that children, teens, and young adults have a lesser chance of experiencing severe symptoms of the coronavirus disease (COVID-19), caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Some people, however, are at a higher risk of severe COVID-19, including the

Early in the pandemic, children were thought to be spared by the coronavirus disease (COVID-19), with a majority experiencing mild or no symptoms at all. The high-risk populations include the elderly, those with underlying health conditions such as diabetes, heart disease, and hypertension, and those who are immunocompromised. Now, new research has found that children

Interstage Home Monitoring (IHM) programs for infants with single ventricle heart defects help families recognize potential complications early and improve infant survival rates and growth prior to the second of multiple surgeries. According to a new Scientific Statement from the American Heart Association, “Interstage Home Monitoring for Infants With Single Ventricle Heart Disease: Education and

Young adults and adolescents who are prescribed opioids for the first time may be at a slightly greater risk of developing a substance-related problem later in life, according to a new study co-authored by Indiana University researchers. However, the risk may not be as high as previously thought. The study was published today in JAMA